Landberg G - Search Results

1

Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator.

Ohshiro K, Rayala SK, Wigerup C, Pakala SB, Natha RS, Gururaj AE, Molli PR, Månsson SS, Ramezani A, Hawley RG, Landberg G, Lee NH, Kumar R. Ohshiro K, et al. Among authors: landberg g. EMBO Rep. 2010 Sep;11(9):691-7. doi: 10.1038/embor.2010.99. Epub 2010 Jul 23. EMBO Rep. 2010. PMID: 20651739 Free PMC article.

2

Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer.

Gururaj AE, Holm C, Landberg G, Kumar R. Gururaj AE, et al. Among authors: landberg g. Cell Cycle. 2006 Jul;5(13):1407-10. doi: 10.4161/cc.5.13.2924. Epub 2006 Jul 1. Cell Cycle. 2006. PMID: 16855396

3

Extranuclear coactivator signaling confers insensitivity to tamoxifen.

Kumar R, Zhang H, Holm C, Vadlamudi RK, Landberg G, Rayala SK. Kumar R, et al. Among authors: landberg g. Clin Cancer Res. 2009 Jun 15;15(12):4123-30. doi: 10.1158/1078-0432.CCR-08-2347. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470742 Free PMC article.

4

MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, Zhang H, Balasenthil S, Talukder AH, Landberg G, Kumar R. Gururaj AE, et al. Among authors: landberg g. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6670-5. doi: 10.1073/pnas.0601989103. Epub 2006 Apr 14. Proc Natl Acad Sci U S A. 2006. PMID: 16617102 Free PMC article.

5

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.

Holm C, Rayala S, Jirström K, Stål O, Kumar R, Landberg G. Holm C, et al. Among authors: landberg g. J Natl Cancer Inst. 2006 May 17;98(10):671-80. doi: 10.1093/jnci/djj185. J Natl Cancer Inst. 2006. PMID: 16705121

6

p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.

Stendahl M, Nilsson S, Wigerup C, Jirström K, Jönsson PE, Stål O, Landberg G. Stendahl M, et al. Among authors: landberg g. Int J Cancer. 2010 Dec 15;127(12):2851-8. doi: 10.1002/ijc.25297. Int J Cancer. 2010. PMID: 21351264 Free article. Clinical Trial.

7

The breast cancer-associated gene Di12 has oncogenic activity.

Burger AM, Grugel R, Landberg G, Kitching R, Seth A. Burger AM, et al. Among authors: landberg g. Anticancer Res. 2003 May-Jun;23(3A):2027-33. Anticancer Res. 2003. PMID: 12894575

8

FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function.

Jensen KS, Binderup T, Jensen KT, Therkelsen I, Borup R, Nilsson E, Multhaupt H, Bouchard C, Quistorff B, Kjaer A, Landberg G, Staller P. Jensen KS, et al. Among authors: landberg g. EMBO J. 2011 Nov 16;30(22):4554-70. doi: 10.1038/emboj.2011.323. EMBO J. 2011. PMID: 21915097 Free PMC article.

9

ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.

Svensson S, Jirström K, Rydén L, Roos G, Emdin S, Ostrowski MC, Landberg G. Svensson S, et al. Among authors: landberg g. Oncogene. 2005 Jun 23;24(27):4370-9. doi: 10.1038/sj.onc.1208626. Oncogene. 2005. PMID: 15806151

10

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.

Jirström K, Stendahl M, Rydén L, Kronblad A, Bendahl PO, Stål O, Landberg G. Jirström K, et al. Among authors: landberg g. Cancer Res. 2005 Sep 1;65(17):8009-16. doi: 10.1158/0008-5472.CAN-05-0746. Cancer Res. 2005. PMID: 16140974 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page